{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:41Z","timestamp":1793766461839,"version":"4.6.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102647","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:37:52Z","timestamp":1786721872000},"page":"102647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Achievement of Ultra-low PSA Levels Correlates With Prolonged Radiologic Progression-free Survival (rPFS) in Metastatic Hormone-sensitive Prostate Cancer (mHSPC)"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-6469","authenticated-orcid":false,"given":"Deniz","family":"Tural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-1921","authenticated-orcid":false,"given":"Fatih","family":"Kemik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Kapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevat \u0130lteri\u015f","family":"K\u0131k\u0131l\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3719-5788","authenticated-orcid":false,"given":"Feyyaz Hazar","family":"Ya\u011fmur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4462-6393","authenticated-orcid":false,"given":"Bahad\u0131r","family":"K\u00f6yl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Sel\u00e7ukbiricik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.clgc.2026.102647_bib0001","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1200\/JCO.2008.19.9810","article-title":"Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916","volume":"27","author":"Hussain","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102647_bib0002","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2017.75.3921","article-title":"Seven-month prostate-specific antigen is prognostic in metastatic hormone-sensitive prostate cancer treated with androgen deprivation with or without Docetaxel","volume":"36","author":"Harshman","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102647_bib0003","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamaoncol.2024.0591","article-title":"Metastatic hormone-sensitive prostate cancer and combination treatment outcomes: a review","volume":"10","author":"Hussain","year":"2024","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102647_bib0004","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.annonc.2025.08.004","article-title":"Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial","volume":"36","author":"Tripathi","year":"2025","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102647_bib0005","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.juro.2014.10.087","article-title":"Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review","volume":"193","author":"Tilki","year":"2015","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102647_bib0006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2026.102647_bib0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2490-14-33","article-title":"Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer","volume":"14","author":"Tomioka","year":"2014","journal-title":"BMC Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102647_bib0008","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/bju.16449","article-title":"Targeted Investigational Treatment Analysis of Novel anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy","volume":"134","author":"Merseburger","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2026.102647_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251369037","article-title":"Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer","volume":"17","author":"Kapar","year":"2025","journal-title":"Ther Adv Med Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102647_bib0010","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.juro.2014.11.017","article-title":"Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy","volume":"193","author":"Kang","year":"2015","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102647_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.annonc.2023.02.009","article-title":"Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer","volume":"34","author":"Chowdhury","year":"2023","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102647_bib0012","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/pros.24847","article-title":"Rapid and deep prostate-specific antigen decline is a prognostic marker in metastatic hormone-sensitive prostate cancer: a real-world multi-intuitional analysis","volume":"85","author":"Suzuki","year":"2025","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.clgc.2026.102647_bib0013","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.euf.2025.03.019","article-title":"Prostate-specific antigen response as a prognostic factor for overall survival in patients with Prostate cancer treated with androgen receptor pathway inhibitors: a systematic review and meta-analysis","volume":"11","author":"Miszczyk","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"15","key":"10.1016\/j.clgc.2026.102647_bib0014","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clgc.2026.102647_bib0015","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3390\/medicina61122110","article-title":"Prognostic significance of ultralow (UL) prostate-specific antigen (PSA) in patients with metastatic hormone-sensitive prostate cancer (mHSPC): a single institution and tertiary cancer center experience","volume":"61","author":"Suton","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.clgc.2026.102647_bib0016","doi-asserted-by":"crossref","DOI":"10.1172\/JCI200920","article-title":"Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine","volume":"136","author":"Bernard-Tessier","year":"2026","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.clgc.2026.102647_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/CCO.0b013e32835105b3","article-title":"The androgen\/androgen receptor axis in prostate cancer","volume":"24","author":"Bluemn","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102647_bib0018","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat Rev Cancer"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:16:53Z","timestamp":1793765813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001473"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102647","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Achievement of Ultra-low PSA Levels Correlates With Prolonged Radiologic Progression-free Survival (rPFS) in Metastatic Hormone-sensitive Prostate Cancer (mHSPC)","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102647"}}